A61K 36/537
Salvia
Official title: Salvia (sage)
A61K36/537 (Salvia) appears on 292 US grants and 509 published applications in this corpus.
Search patents in A61K- Granted patents
- 292
- Published applications
- 509
- Assignees
- 277
- Inventors
- 1,130
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 2 | 0 |
| 1991 | 5 | 0 |
| 1992 | 0 | 0 |
| 1993 | 2 | 0 |
| 1994 | 1 | 0 |
| 1995 | 4 | 0 |
| 1996 | 1 | 0 |
| 1997 | 2 | 0 |
| 1998 | 2 | 0 |
| 1999 | 8 | 0 |
| 2000 | 6 | 0 |
| 2001 | 7 | 3 |
| 2002 | 9 | 15 |
| 2003 | 9 | 13 |
| 2004 | 3 | 14 |
| 2005 | 3 | 20 |
| 2006 | 0 | 15 |
| 2007 | 0 | 19 |
| 2008 | 5 | 8 |
| 2009 | 4 | 15 |
| 2010 | 4 | 13 |
| 2011 | 4 | 14 |
| 2012 | 7 | 16 |
| 2013 | 6 | 22 |
| 2014 | 17 | 22 |
| 2015 | 20 | 22 |
| 2016 | 9 | 26 |
| 2017 | 10 | 16 |
| 2018 | 19 | 14 |
| 2019 | 14 | 23 |
| 2020 | 18 | 30 |
| 2021 | 22 | 36 |
| 2022 | 20 | 29 |
| 2023 | 10 | 28 |
| 2024 | 13 | 40 |
| 2025 | 10 | 17 |
| 2026 | 15 | 19 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Extract of bacteria of the genus Sphingomonas29 Sep 2026US 12,746,260 B2L'oreal
- Botanicals as WNT/beta-catenin activators, molecular pathway regulators, tissue regenerators and health biomarker regulators18 Aug 2026US 12,708,655 B2Arbor Life Holdings, Ltd.
- Extract of an herbal composition as antimicrobial and/or antibiofilm agent11 Aug 2026US 12,702,691 B2Alphanosos S.A.S.
- Use of a vegetal extract from Salvia haenkei as an active agent in the treatment of a musculoskeletal disorder26 May 2026US 12,636,336 B2Ibsa Institut Biochimique SA
- Pharmaceutical composition and application thereof12 May 2026US 12,622,888 B2Shanghai Institute of Materia Medica, Chinese Academy of Sciences
- Traditional chinese medicine composition for treating post-coronary heart disease depression, preparation method and application thereof1 Oct 2026US 2026/0294984 A1Hangzhou Hongyu Pharmaceutical Technology Co., Ltd.
- Fast absorbing trolamine salicylate formulations and compositions27 Aug 2026US 2026/0248818 A1Thee, Inc.
- Compositions derived from salvia hispanica seeds20 Aug 2026US 2026/0240933 A1Signum Dermalogix, Inc.
- Method for preparing eye-soothing externally-applied liquid medicine and method for external application thereof13 Aug 2026US 2026/0232650 A1
- Composition for preventing hair loss or promoting hair growth comprising chia seed mucilage13 Aug 2026US 2026/0232748 A1Industry-Academic Cooperation Foundation, Yonsei University
Most cited
By later US patents
- Use of essential oils to increase bioavailability of oral pharmaceutical compounds101US 5,716,928 AAvMax, Inc. · 1998
- Compositions and method of treating cardio-, cerebro-vascular and alzheimer's diseases and depression64US 5,589,182 A1996
- Pharmaceutical compositions for the treatment of skin disorders60US 5,466,452 APhytopharm PLC · 1995
- Use of essential oils to increase bioavailability of orally administered pharmaceutical compounds56US 6,121,234 AAvMax, Inc. · 2000
- Bioactive botanical cosmetic compositions and processes for their production40US 7,442,391 B2Integrated Botanical Technologies, LLC · 2008